COVID-19: Canada Responds: Vaccine Advisory Group OKs AstraZeneca Vaccine For Adults 65 and Over

Vaccine Advisory Group OKs AstraZeneca Vaccine For Adults 65 and Over
In a virtual news conference, federal health officials and representatives from the National Advisory Committee on Immunization (NACI) discuss changes to recommendations concerning the administering of COVID-19 vaccines. NACI has expanded its age group for AstraZeneca vaccines to now include adults 65 years of age and older. Speaking with reporters are Dr. Caroline Quach-Thanh, chair of NACI; Dr. Matthew Tunis, executive secretary of NACI, and Dr. Marc Berthiaume, the director of the Bureau of Medical Science at Health Canada. The updated guideline comes as several European countries have suspended their use of the AstraZeneca vaccine over concerns of blood clots. (March 16, 2021)

Related Keywords

Canada ,Caroline Quach Thanh ,Marc Berthiaume ,Astrazeneca ,National Advisory Committee On Immunization ,Bureau Of Medical Science At Health Canada ,Vaccine Advisory Group Oks Astrazeneca ,Vaccine Advisory Group ,Astrazeneca Vaccine For Adults ,National Advisory Committee ,Matthew Tunis ,Medical Science ,கனடா ,கரோலின் குவாச் த்யாந் ,மார்க் பெர்த்தியாம் ,பணியகம் ஆஃப் மருத்துவ அறிவியல் இல் ஆரோக்கியம் கனடா ,மேத்யூ துனிஸ் ,மருத்துவ அறிவியல் ,